Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Pharmacol Exp Ther ; 297(2): 704-10, 2001 May.
Article in English | MEDLINE | ID: mdl-11303061

ABSTRACT

The virucidal protein cyanovirin-N (CV-N) mediates its highly potent anti-human immunodeficiency virus activity, at least in part, through interactions with the viral envelope glycoprotein gp120. Here we dissect in further detail the mechanism of CV-N's glycosylation-dependent binding to gp120. Isothermal titration calorimetry (ITC) binding studies of CV-N with endoglycosidase H-treated gp120 showed that binding was completely abrogated by removal of high-mannose oligosaccharides from the glycoprotein. Additional ITC and circular dichroism spectral studies with CV-N and other glycoproteins as well showed that CV-N discriminately bound only glycoproteins that contain high-mannose oligosaccharides. Binding experiments with RNase B indicated that the single high-mannose oligosaccharide on that enzyme mediated all of its binding with CV-N (K(d) = 0.602 microM). A finer level of oligosaccharide selectivity of CV-N was revealed in affinity chromatography-liquid chromatography-mass spectrometry experiments, which showed that CV-N preferentially bound only oligomannose-8 (Man-8) and oligomannose-9 isoforms of RNase B. Finally, we biophysically characterized the interaction of CV-N with a purified, single oligosaccharide, Man-8. The binding affinity of Man-8 for CV-N is unusually strong (K(d) = 0.488 microM), several hundredfold greater than observed for oligosaccharides and their protein lectins (K(d) = 1 microM--1 mM), further establishing a critical role of high-mannose oligosaccharides in CV-N binding to glycoproteins.


Subject(s)
Anti-HIV Agents/pharmacology , Bacterial Proteins , Carrier Proteins/pharmacology , Glycoproteins/drug effects , HIV Envelope Protein gp120/drug effects , Oligosaccharides/pharmacology , Calorimetry , Chromatography, Affinity , Circular Dichroism , Humans , Mannose/pharmacology , Molecular Conformation , Ribonucleases/metabolism , Spectrometry, Mass, Electrospray Ionization , Thermodynamics
2.
J Nat Prod ; 64(1): 117-21, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11170684

ABSTRACT

Microspinosamide (1), a new cyclic depsipeptide incorporating 13 amino acid residues, was isolated from extracts of an Indonesian collection of the marine sponge Sidonops microspinosa. Its structure was elucidated by extensive NMR and mass spectral analyses, and by chemical degradation and derivatization studies. The tridecapeptide 1 incorporates numerous uncommon amino acids, and it is the first naturally occurring peptide to contain a beta-hydroxy-p-bromophenylalanine residue. Microspinosamide (1) inhibited the cytopathic effect of HIV-1 infection in an XTT-based in vitro assay with an EC(50) value of approximately 0.2 microg/mL.


Subject(s)
Anti-HIV Agents/isolation & purification , Depsipeptides , Oligopeptides/isolation & purification , Peptides, Cyclic/isolation & purification , Porifera/chemistry , Animals , Anti-HIV Agents/chemistry , Anti-HIV Agents/pharmacology , Chromatography, Liquid , Cytopathogenic Effect, Viral/drug effects , HIV-1/drug effects , Magnetic Resonance Spectroscopy , Oligopeptides/chemistry , Oligopeptides/pharmacology , Peptides, Cyclic/chemistry , Peptides, Cyclic/pharmacology , Spectrometry, Mass, Fast Atom Bombardment
SELECTION OF CITATIONS
SEARCH DETAIL
...